Stichting Sanquin Bloedvoorziening
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Stichting Sanquin Bloedvoorziening - overview
Established
1998
Location
Amsterdam, -, Netherlands
Primary Industry
Pharmaceuticals
About
Founded in 1998 and based in Amsterdam, Netherlands, Stichting Sanquin Bloedvoorziening focuses on developing medicinal products derived from blood, provides diagnostic services and conducts scientific research.
Primary Industry
Pharmaceuticals
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development, Search Engines
Website
www.sanquin.org
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Stichting Sanquin Bloedvoorziening - timeline of key events
Stichting Sanquin Bloedvoorziening - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 393,375,000 | 418,705,000 | 430,400,000 | 388,656,000 | 433,192,000 | 448,066,000 | 399,158,000 | 378,017,000 | 248,500,000 | - | - | - |
| % Revenue Growth (YoY) | - | 6.4% | 2.8% | (9.7%) | 11.5% | 3.4% | (10.9%) | (5.3%) | (34.3%) | - | - | - |
| EBITDA (USD) | 50,363,000 | 4,342,000 | 42,763,000 | 55,066,000 | 43,427,000 | 89,506,000 | 11,771,000 | 1,120,000 | 19,353,000 | - | - | - |
| Operating Income (USD) | 25,119,000 | (23,021,000) | 11,504,000 | 23,334,000 | 14,672,000 | 60,955,000 | (16,922,000) | (39,611,000) | 10,800,000 | - | - | - |
| Operating Margin | 6.4% | (5.5%) | 2.7% | 6.0% | 3.4% | 13.6% | (4.2%) | (10.5%) | 4.3% | - | - | - |
| % EBITDA Margin | 12.8% | 1.0% | 9.9% | 14.2% | 10.0% | 20.0% | 2.9% | 0.3% | 7.8% | - | - | - |
| NET Income (USD) | 16,930,000 | (16,542,000) | 6,565,000 | 14,202,000 | 10,816,000 | 48,711,000 | (15,481,000) | 36,897,000 | 4,612,000 | - | - | - |
| % Net Margin | 4.3% | (4.0%) | 1.5% | 3.7% | 2.5% | 10.9% | (3.9%) | 9.8% | 1.9% | - | - | - |
Stichting Sanquin Bloedvoorziening - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Direct Diagnostics B.V. | - | ||||||||
| Add-on | Completed | Plasma Industries Belgium bv – srl | - | ||||||||
| Buyout | Completed | Sanquin Plasma Products B.V. | - |
Displaying 1 - 3 of 3
Stichting Sanquin Bloedvoorziening - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.